טוען...
The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform
The development of resources for clinical interpretation of cancer-associated genetic alterations has significantly lagged behind the technical developments enabling their detection in a time-and cost-efficient manner. The lack of scientific and informatics decision support for oncologists can lead...
שמור ב:
| הוצא לאור ב: | Drug Discov Today |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5648066/ https://ncbi.nlm.nih.gov/pubmed/26148707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2015.05.013 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|